AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.3450
-0.0181 (-4.98%)
Jun 24, 2026, 10:16 AM EDT - Market open
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $7.62 million as of June 24, 2026. Its market cap has increased by 40.21% in one year.
Market Cap
7.62M
Enterprise Value
6.71M
1-Year Change
40.21%
Ranking
Category
Stock Price
$0.35
Market Cap Chart
Since July 12, 1996, AIM ImmunoTech's market cap has decreased from $40.85M to $7.62M, a decrease of -81.35%. That is a compound annual growth rate of -5.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 22, 2026 | 8.46M | 162.27% |
| Dec 31, 2025 | 3.22M | -74.47% |
| Dec 31, 2024 | 12.63M | -41.22% |
| Dec 29, 2023 | 21.49M | 43.27% |
| Dec 30, 2022 | 15.00M | -65.93% |
| Dec 31, 2021 | 44.02M | -39.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Cadrenal Therapeutics | 8.78M |
| PharmaCyte Biotech | 8.33M |
| Addex Therapeutics | 8.33M |
| Bolt Biotherapeutics | 8.24M |
| Aspire Biopharma Holdings | 7.99M |
| MetaVia | 7.95M |
| Immuron | 7.92M |
| Curanex Pharmaceuticals | 7.77M |